Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.11SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17222.6Japan
FG.2SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17222.6Japan
B.1.526 (Iota)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
MH.1SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
LB.1.3.2SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
BQ.1.21SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
BA.2.63SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
B.1.258.15SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-17217.9Japan
CP.7ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-17214.3Japan
MD.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-17214.3Japan
B.1.1.138ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-17214.3Japan
XBB.1.5.85NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-17208.2US
KP.2.13NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-17205US
CM.9NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-17205US
BE.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17195.6Germany
BQ.1.1.43ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17195.6Germany
EZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17195.6Germany
EE.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-17162.5Japan
AM.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-17162.5Japan
B.1.273ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
B.1.177.21ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
B.1.415.1ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
HK.3.7ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
XBB.1.16.16ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
HW.1.1ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
BQ.1.1.24ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
B.1.623ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
JN.1.61ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-17161.5China
AY.120.1 (Delta)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
BE.10ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
JW.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
D.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
BF.39.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
GA.7.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-17139.9Singapore
XBB.1.5.56SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-17139.2China
HG.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-17135.3Japan
HH.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-17131.6South Korea
GW.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17130.7Japan
AY.112.3 (Delta)SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17130.7Japan
AY.117 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-17128.2France
AY.46.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-17128.2France
B.1.402NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
A.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.177.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.177.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.163NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used